latestnews

27 Sep TissueGen Founder and CSO Dr. Kevin Nelson to Present “Latest Advancement in Extrusion Technology for Drug Delivery Applications” Session at the IFAI Expo

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic and medical device companies to develop fiber and textile medical devices for use in...

Read More

23 May TissueGen to Feature ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East

WHO: TissueGen® Inc., developer of patented ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration, and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic, and medical device companies to develop fiber and textile medical devices for use...

Read More

13 Apr TissueGen Founder and CSO Dr. Kevin Nelson to Present “Enabling the Next Generation of Drug Delivery through Implantable Medical Devices” Session at BIOMEDevice Boston

WHO: TissueGen® Inc., developer of ELUTE® fiber, enables controlled sustained delivery of sensitive pharmaceuticals and biologics from biodegradable fibers for advanced drug delivery, nerve regeneration and tissue engineering. TissueGen works with leading pharmaceutical, therapeutic and medical device companies to develop fiber and textile medical devices for use in drug...

Read More

07 Jun TissueGen Wins MedTech Breakthrough Award

TissueGen’s ELUTE® Fiber Recognized with Medical Device Engineering Breakthrough Award DALLAS, TX, June 7, 2017 – TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering, today announced that it has been selected as the winner of the “Medical...

Read More

01 Jun TissueGen to Highlight ELUTE® Fiber for Advanced Drug Delivery, Nerve Regeneration and Tissue Engineering at MD&M East

Explore How ELUTE® Fiber is Ideal for Orthopedic Applications Requiring Targeted Cell Migration and Tissue Growth WHO: TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering. WHAT: TissueGen will exhibit patented ELUTE fiber in booth 2029...

Read More